ONS 2013 Intro

Article

Cancer Network brings exclusive coverage of content and expert perspectives from the 38th annual Oncology Nursing Society Congress, held April 25–28, 2013 at the Walter E. Washington Convention Center in Washington, DC. Through educational sessions and symposia, podium and poster presentations, workshops, and special interest group (SIG) meetings, ONS Congress provides myriad opportunities to learn about innovations in cancer treatment and supportive care; ways to integrate and promote evidence-based practice to improve patient outcomes and quality of life; strategies for nursing self-care; and approaches to support professional growth.

 

Cancer Network brings exclusive coverage of content and expert perspectives from the 38th annual Oncology Nursing Society Congress, held April 25–28, 2013 at the Walter E. Washington Convention Center in Washington, DC. Through educational sessions and symposia, podium and poster presentations, workshops, and special interest group (SIG) meetings, ONS Congress provides myriad opportunities to learn about innovations in cancer treatment and supportive care; ways to integrate and promote evidence-based practice to improve patient outcomes and quality of life; strategies for nursing self-care; and approaches to support professional growth.

Related Videos
FDA-approved immunotherapy options such as atezolizumab and durvalumab have produced substantial benefits in certain groups of patients with extensive-stage small cell lung cancer, says Gregory Peter Kalemkerian, MD.
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey Anders, MD, an expert on breast cancer
Carey K. Anders, MD, an expert on breast cancer
A panel of 4 experts on breast cancer seated at a long table
A panel of 4 experts on breast cancer seated at a long table
A panel of 4 experts on breast cancer seated at a long table
The use of a single-port robot may allow for surgically treating more patients with head and neck cancer in a more timely manner, according to Hilary McCrary, MD, MPH.
A panel of 5 experts on colorectal cancer